Evidence mapPaperPMID 40998019Full record

ArticleThe American journal of clinical nutrition2025

Obesity promotes conserved inflammatory and metabolic transcriptional programs in colon tumors: evidence from mouse models and the ColoCare Study Patient Cohort.

Elaine M Glenny, Tengda Lin, Victoria M Bandera, Babak Mirminachi, Saratchandra S Khumukcham, Biljana Gigic, Christy A Warby, Olena Aksonova, Michael F Coleman, Alessandro Carpanese and 23 more

Abstract read
In one paragraph

Article in The American journal of clinical nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

33 authors.

Elaine M GlennyDepartment of Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
Tengda LinDepartment of Population Health Sciences, University of Utah, Salt Lake City, UT, United States; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.
Victoria M BanderaDepartment of Population Health Sciences, University of Utah, Salt Lake City, UT, United States; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.
Babak MirminachiDivision of Gastroenterology, Department of Medicine, Duke University, Durham, NC, United States.
Saratchandra S KhumukchamDivision of Gastroenterology, Department of Medicine, Duke University, Durham, NC, United States.
Biljana GigicDepartment of General, Visceral, and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany.
Christy A WarbyDepartment of Population Health Sciences, University of Utah, Salt Lake City, UT, United States; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.
Olena AksonovaDepartment of Population Health Sciences, University of Utah, Salt Lake City, UT, United States; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.
Michael F ColemanDepartment of Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
Alessandro CarpaneseDivision of Gastroenterology, Department of Medicine, Duke University, Durham, NC, United States.
Calista BuschDivision of Gastroenterology, Department of Medicine, Duke University, Durham, NC, United States.
Caroline HimbertDepartment of Population Health Sciences, University of Utah, Salt Lake City, UT, United States; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.
Jennifer OseDepartment of Population Health Sciences, University of Utah, Salt Lake City, UT, United States; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States; Department of Information and Communication, University of Applied Sciences and Arts, Hannover, Germany.
David A NixCancer Bioinformatics Shared Resource, Huntsman Cancer Institute, Salt Lake City, UT, United States.
Kenneth BoucherCancer Biostatistics Shared Resource, Huntsman Cancer Institute, Division of Epidemiology, University of Utah, Salt Lake City, UT, United States.
Peter SchirmacherInstitute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
Ildiko StrehliHuntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.
Sheetal HardikarDepartment of Population Health Sciences, University of Utah, Salt Lake City, UT, United States; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.
Jessica N CohanHuntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.
Jolanta JedrzkiewiczHuntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States; Department of Pathology, Huntsman Cancer Institute, Salt Lake City, UT, United States.
Alexander BrobeilInstitute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
Martin A SchneiderDepartment of General, Visceral, and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany; Klinik für Allgemein-, Viszeral- Thorax-, Transplantations- und Kinderchirurgie, Universitätsklinikum Gießen und Marburg GmbH, Heidelberg, Germany.
Christoph KahlertDepartment of General, Visceral, and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany.
Erin M SiegelDepartment of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.
Doratha A ByrdDepartment of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States.
Adetunji T ToriolaDivision of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, MO, United States; Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, United States.
David ShibataDepartment of Surgery, University of Tennessee Health Science Center, Memphis, TN, United States.
Christopher I LiDivision of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Jane C FigueiredoDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Aik Choon TanHuntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States; Cancer Bioinformatics Shared Resource, Huntsman Cancer Institute, Salt Lake City, UT, United States; Departments of Oncological Sciences and Biomedical Informatics, University of Utah, Salt Lake City, UT, United States.
Jatin RoperDivision of Gastroenterology, Department of Medicine, Duke University, Durham, NC, United States; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, United States; Department of Cell Biology, Duke University, Durham, NC, United States. Electronic address: jatin.roper@duke.edu.
Cornelia M UlrichDepartment of Population Health Sciences, University of Utah, Salt Lake City, UT, United States; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States. Electronic address: neli.ulrich@hci.utah.edu.
Stephen D HurstingDepartment of Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; Nutrition Research Institute, University of Carolina at Chapel Hill, Kannapolis, NC, United States; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. Electronic address: hursting@email.unc.edu.

Funding

Tissue CoreP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · 1998 to 2025
$32.8M
UTAH REGIONAL CANCER CENTERP30CA042014 · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · 1986 to 2025
$11.4M
Ceramides as novel drivers of metabolic dysfunction and colorectal cancerU01CA272529 · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · 2025 to 2025
$992k
Geriatric assessment domains in relation to treatment outcomes among older adults with colorectal cancerR01AG083580 · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · 2025 to 2025
$759k
Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer linkR01CA254108 · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · 2025 to 2025
$627k
NCI NIH HHS P30 CA042014NCI NIH HHS P30 CA076292NCI NIH HHS R01 CA254108NCI NIH HHS U01 CA272529NIA NIH HHS R01 AG083580
6 · The paper itself

Abstract

backgroundThe global prevalence of obesity, an established risk and progression factor for colon cancer, is high and rising. Unfortunately, the mechanisms underlying the obesity-colon cancer association are incompletely understood, and new molecular targets enabling more effective intervention strategies to break the obesity-colon cancer link are urgently needed.

objectivesThis study integrated RNA sequencing data from mouse and human colon tumor samples, as well as human adipose samples, to rigorously establish obesity-associated transcriptomic signatures conserved between the 2 species.

methodsWe employed a mouse colon cancer model with colonoscopy-guided orthotopic transplantation of syngeneic Apc

resultsDiet-induced obesity reduced survival in the mouse model of colon cancer. Integrated transcriptomic analyses of EpCAM-positive murine tumor cells and bulk human tumors revealed obesity-driven enrichment of inflammation and metabolic pathways, including the upregulation of genes involved in innate immune sensing (TLR2, MYD88, and IRF4) and tumor microenvironment remodeling (MMP9, TGFB1, and SERPINE1). Analysis of paired mesenteric visceral adipose tissue and tumor samples from the study patients (63 ± 13 y, 48% female, body mass index 28.9 ± 6.0 kg/m

conclusionsThese results establish obesity-associated adipose tissue dysregulation as a key intertissue modulator of biology, with concordant cross-species effects on tumor cell-intrinsic inflammatory and metabolic programs.

Indexed as

Colonic NeoplasmsInflammationObesityAdipose TissueAnimalsCohort StudiesDisease Models, AnimalFemaleHumansMaleMiceMice, Inbred C57BLTranscriptomecolon cancerinflammationligand-receptor interactionsmetabolismobesityRNA sequencingvisceral adipose tissue

Identifiers

PMID40998019
PMCPMC12799463

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.